« Back
Home /
Triciribine

Triciribine

Item no.	M1884-200mg
Manufacturer	AbMole
CASRN	35943-35-2
Amount	200mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Heart & Blood Cancer
Type	Inhibitors
Specific against	other
Purity	>98.5%
Citations	AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors. Gloesenkamp CR, et al . Int J Oncol. 2012 Mar,40(3):876-88. PMID: 22075556 . Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia. Evangelisti C, et al . J Cell Physiol. 2011 Mar,226(3):822-31. PMID: 20857426 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	API-2, NSC 154020, TCN
Similar products	Triciribine, API-2, NSC 154020, TCN
Available
Target Information	Akt
Molecular Weight	320, 3
Solubility	DMSO 54 mg/mL
Bioactivity information	Triciribine (API-2, NSC 154020) is a selective inhibitor of Akt (protein kinase B) signaling with IC50 of 130 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1884-200mg-safety-datasheet.pdf